Tumour necrosis factor α antagonists and early postoperative complications in patients with inflammatory joint disease undergoing elective orthopaedic surgery
- 1 April 2005
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 64 (4) , 650-651
- https://doi.org/10.1136/ard.2004.028365
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Tuberculosis following the Use of Etanercept, a Tumor Necrosis Factor InhibitorClinical Infectious Diseases, 2004
- Perioperative management of patients with rheumatoid arthritis in the era of biologic response modifiersCurrent Opinion in Rheumatology, 2004
- Early Postoperative Complications are not Increased in Patients with Crohn's Disease Treated Perioperatively with Infliximab or Immunosuppressive TherapyAmerican Journal of Gastroenterology, 2004
- The risk of post‐operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort studyAlimentary Pharmacology & Therapeutics, 2004
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgeryAnnals of the Rheumatic Diseases, 2001
- Tumor Necrosis Factor and Wound HealingAnnals of Surgery, 1990